CEP-701 (Lestaurtinib) in Myelofibrosis

Clinical trial NCT00668421 · UNKNOWN

Trial details

NCT number: NCT00668421
Sponsor: Ronald Hoffman
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelofibrosis Essential Thrombocythemia Polycythemia Vera

Start date: 2008-04-01
Primary completion: 2013-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.